David W Gryska's Net Worth
$25.6 Million
Who is David W Gryska?
David W Gryska has an estimated net worth of $25.6 Million. This is based on reported shares across multiple companies, which include Seagen Inc., GW PHARMACEUTICALS PLC, INCYTE CORP, COTHERIX INC, HYPERION THERAPEUTICS INC, AERIE PHARMACEUTICALS INC, CELGENE CORP /DE/, Mind Medicine (MindMed) Inc., Forte Biosciences, Inc., PDL BIOPHARMA, INC., ARGOS THERAPEUTICS INC, and Myrexis, Inc..
SEC CIK
David W Gryska's CIK is 0001202335
Past Insider Trading and Trends
2022 was David W Gryska's most active year for acquiring shares with 15 total transactions. David W Gryska's most active month to acquire stocks was the month of April. 2022 was David W Gryska's most active year for disposing of shares, totalling 27 transactions. David W Gryska's most active month to dispose stocks was the month of October. 2017 saw David W Gryska paying a total of $4,298,574.20 for 168,697 shares, this is the most they've acquired in one year. In 2023 David W Gryska cashed out on 122,934 shares for a total of $11,221,687.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Seagen Inc. (SGEN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -49.00K |
$229.00 | -$11,221,687.00 |
0
|
Dec 14
| |||
Form 4
| +4.17% | 2.04K |
—
|
—
| 51.05K |
May 31
| |||
Form 4
| +21.74% | 8.75K |
$36.70 | $321,125.00 | 49K |
Feb 13
| |||
Form 4
| -15.71% | -7.50K |
$129.10 | -$968,220.00 | 40.25K |
Nov 11
| |||
Form 4
| +3.25% | 1.5K |
—
|
—
| 47.75K |
May 13
| |||
Form 4
|
—
|
0
|
$82.01 | -$495,543.00 | 46.25K |
Scheduled
|
Apr 19
| ||
Form 4
|
—
|
0
|
$79.41 | -$534,170.96 | 46.25K |
Scheduled
|
Feb 7
| ||
Form 4
|
—
|
0
|
$71.31 | -$461,268.88 | 46.25K |
Scheduled
|
Jan 28
| ||
Form 4
|
—
|
0
|
$77.65 | -$518,310.90 | 46.25K |
Scheduled
|
Jan 14
| ||
Form 4
| +3.13% | 1.4K |
—
|
—
| 46.25K |
May 14
| |||
Form 4
|
—
|
0
|
$96.36 | -$2,320,222.55 | 44.85K |
Nov 19
| |||
Form 4
| -9.12% | -4.50K |
$180.60 | -$812,699.10 | 44.85K |
Nov 5
| |||
Form 4
| +2.78% | 1.33K |
—
|
—
| 49.35K |
May 15
| |||
Form 4
|
—
|
0
|
$50.49 | -$346,000.00 | 48.01K |
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$43.88 | -$311,200.00 | 48.01K |
Scheduled
|
Jul 17
| ||
Form 4
| +6.58% | 2.96K |
—
|
—
| 48.01K |
May 20
| |||
Form 4
|
—
|
0
|
$43.09 | -$303,229.78 | 45.05K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$38.90 | -$261,400.00 | 45.05K |
Scheduled
|
Jan 8
| ||
Form 4
| +8.95% | 3.7K |
—
|
—
| 45.05K |
May 18
| |||
Form 4
| +9.83% | 3.7K |
—
|
—
| 41.35K |
May 19
| |||
Form 4
| +36.17% | 10K |
$10.20 | $102,000.00 | 37.65K |
Sep 6
| |||
Form 4
| +15.45% | 3.7K |
—
|
—
| 27.65K |
May 20
| |||
Form 4
| -29.46% | -10.00K |
$43.57 | -$435,737.00 | 23.95K |
Nov 5
| |||
Form 4
| +12.23% | 3.7K |
—
|
—
| 33.95K |
May 15
| |||
Form 4
| +19.80% | 5K |
$8.38 | $41,900.00 | 30.25K |
Apr 8
| |||
Form 4
| +16.09% | 3.5K |
—
|
—
| 25.25K |
May 16
| |||
Form 4
|
—
|
0
|
$26.28 | -$324,000.00 | 22K |
Sep 3
| |||
Form 4
| +18.92% | 3.5K |
—
|
—
| 22K |
May 17
| |||
Form 4
|
—
|
0
|
$16.93 | -$204,800.00 | 18.5K |
Feb 25 - Feb 26
| |||
Form 4
| +65.22% | 7.5K |
$5.00 | $37,500.00 | 19K |
Aug 10
| |||
Form 4
| -41.03% | -8.00K |
$19.75 | -$158,000.00 | 11.5K |
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +30.00% | 4.5K |
$5.00 | $22,500.00 | 19.5K |
Dec 15
| |||
Form 4
| -40.00% | -10.00K |
$18.09 | -$180,917.00 | 15K |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +18.60% | 4K |
$5.00 | $20,000.00 | 25.5K |
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
| +22.86% | 4K |
$4.18 | $16,720.00 | 21.5K |
Feb 17
| |||
Form 4
| +29.63% | 4K |
$5.00 | $20,000.00 | 17.5K |
Jul 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
| +80.00% | 6K |
$4.18 | $25,080.00 | 13.5K |
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| +50.00% | 2.5K |
$4.59 | $11,484.00 | 7.5K |
May 9
| |||
Form 4
|
∞
| 5K |
$4.91 | $24,574.48 | 5K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GW PHARMACEUTICALS PLC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INCYTE CORP (INCY) Snapshot price: $57.59
Executive Vice President, CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.26% | -455.00 |
$70.19 | -$31,936.45 | 10.23K |
Jul 16
| |||
Form 4
| -2.55% | -280.00 |
$68.28 | -$19,118.40 | 10.69K |
Jul 2 - Jul 5
| |||
Form 4
| -21.60% | -3.02K |
$85.73 | -$259,065.22 | 10.97K |
Scheduled
|
Feb 20 - Feb 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
$91.35 | -$101,670.40 | 13.99K |
Scheduled
|
Jan 5
| ||
Form 4
| -35.88% | -7.83K |
$106.79 | -$835,988.93 | 13.99K |
Scheduled
|
Nov 1 - Nov 2
| ||
Form 4
| -3.16% | -712.00 |
$123.15 | -$87,682.80 | 21.82K |
Sep 13
| |||
Form 4
| +18.50% | 3.52K |
—
|
—
| 22.53K |
Jul 5
| |||
Form 4
|
—
|
0
|
$101.48 | -$33,861.47 | 19.02K |
Scheduled
|
Jun 30
| ||
Form 4
|
—
|
0
|
$94.91 | -$727,042.84 | 19.02K |
Scheduled
|
Jun 12
| ||
Form 4
|
—
|
0
|
$95.66 | -$79,450.80 | 19.02K |
Scheduled
|
Apr 28
| ||
Form 4
|
—
|
0
|
$102.53 | -$2,945,996.32 | 19.02K |
Scheduled
|
Apr 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| +41.27% | 5.55K |
—
|
—
| 19.02K |
Jul 15
| |||
Form 4
| +24.06% | 2.61K |
—
|
—
| 13.46K |
Jan 7
| |||
Form 4
| +38.61% | 3.02K |
—
|
—
| 10.85K |
Jan 8
| |||
Form 4
|
∞
| 7.83K |
—
|
—
| 7.83K |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
COTHERIX INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HYPERION THERAPEUTICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||